Evidence map›Paper›PMID 42390690›Full record

ArticlePhotochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology2026

Chlorin e6-mediated sublethal photodynamic therapy modulates biomarkers in a murine lung cancer-derived in vitro cancer-associated fibroblast model.

Shuntianci Zhang, Jun Shi, Fan Leng, Liu-Gen Li, Chen-Yu Wang, Ning Han, Jun Hu, Tong-Fei Li, Xing-Chun Peng

Abstract read
PubMed Publisher
In one paragraph

Article in Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Shuntianci Zhang *Shiyan Key Laboratory of Natural Medicine Nanoformulation Research, Hubei Key Laboratory of Embryonic Stem Cell Research, School of Basic Medical Sciences, Hubei University of Medicine, Renmin Road No. 30, Shiyan, 442000, Hubei, China.
Jun Shi *Department of Pediatric Stomatology, Shenzhen Stomatology Hospital (Pingshan) of Southern Medical University, Shenzhen, 518000, Guangdong, China.
Fan LengShiyan Key Laboratory of Natural Medicine Nanoformulation Research, Hubei Key Laboratory of Embryonic Stem Cell Research, School of Basic Medical Sciences, Hubei University of Medicine, Renmin Road No. 30, Shiyan, 442000, Hubei, China.
Liu-Gen LiShiyan Key Laboratory of Natural Medicine Nanoformulation Research, Hubei Key Laboratory of Embryonic Stem Cell Research, School of Basic Medical Sciences, Hubei University of Medicine, Renmin Road No. 30, Shiyan, 442000, Hubei, China.
Chen-Yu WangShiyan Key Laboratory of Natural Medicine Nanoformulation Research, Hubei Key Laboratory of Embryonic Stem Cell Research, School of Basic Medical Sciences, Hubei University of Medicine, Renmin Road No. 30, Shiyan, 442000, Hubei, China.
Ning HanShiyan Key Laboratory of Natural Medicine Nanoformulation Research, Hubei Key Laboratory of Embryonic Stem Cell Research, School of Basic Medical Sciences, Hubei University of Medicine, Renmin Road No. 30, Shiyan, 442000, Hubei, China.
Jun HuShiyan Key Laboratory of Natural Medicine Nanoformulation Research, Hubei Key Laboratory of Embryonic Stem Cell Research, School of Basic Medical Sciences, Hubei University of Medicine, Renmin Road No. 30, Shiyan, 442000, Hubei, China.
Tong-Fei LiShiyan Key Laboratory of Natural Medicine Nanoformulation Research, Hubei Key Laboratory of Embryonic Stem Cell Research, School of Basic Medical Sciences, Hubei University of Medicine, Renmin Road No. 30, Shiyan, 442000, Hubei, China. Litongfeihappy@163.com.ORCID https://orcid.org/0000-0002-9245-6165
Xing-Chun PengDepartment of Pathology, Shenzhen Pingle Orthopedic Hospital (Shenzhen Pingshan Traditional Chinese Medicine Hospital), Shenzhen, 518118, Guangdong, China. pxcun118@163.com.ORCID https://orcid.org/0000-0002-1520-3252

Funding

Research Project of Shenzhen Pingshan District Health Administration 2024211
6 · The paper itself

Abstract

objectiveCancer-associated fibroblasts (CAF) account for a high proportion in most solid tumors, including lung cancer, where they exert immunosuppressive function and thereby facilitate cancer progression. Photodynamic therapy (PDT) destroys malignant cells through photo-mediated ROS generation, but its effects on CAF have not been fully explored. The present study aims to investigate these effects and the involved molecular mechanism. MATERIALS AND

methodsThe CAF model was established using L929 fibroblasts and Lewis lung cancer cells-derived conditioned medium (LLC CM). Laser-irradiated Chlorin e6 (Ce6) was harnessed to drive PDT. The biomarkers of CAF were detected by Western blotting. Intracellular oxidative stress was analyzed using fluorescence probes and flow cytometry. The dehydrogenase activity (cell viability) of CAF was assessed using the CCK-8 assay.

resultsHigh expression of α-SMA, FAP, and PDGFRβ was identified in the Lewis cell-derived conditioned medium-stimulated CAF. The photosensitizer Ce6 was effectively internalized by CAF without compromising cell dehydrogenase activity under the selected conditions. Further investigation revealed that the screened sublethal Ce6-PDT potentiated a more aggressive phenotype of CAF. Mechanistically, this effect was linked to the reactive oxygen species (ROS) generation and activation of the MAPK signaling pathway driven by oxidative stress. Suppression of oxidative stress and MAPK signaling successfully reversed the aforementioned effect of PDT on CAF activation.

conclusionTaken together, Ce6-mediated sublethal PDT under specific conditions further promotes CAF activation by oxidative stress and the downstream MAPK signaling pathway, thereby regulating the lung cancer microenvironment. As a study deciphering PDT-mediated regulation of CAF in the tumor immune microenvironment, our work constitutes a pioneering and highly significant exploratory effort.

Indexed as

Cancer-Associated FibroblastsLung NeoplasmsPhotochemotherapyPhotosensitizing AgentsPorphyrinsAnimalsCarcinoma, Lewis LungCell Line, TumorCell SurvivalChlorophyllidesMiceOxidative StressReactive Oxygen SpeciesChlorophyllidesPhotosensitizing AgentsphytochlorinPorphyrinsReactive Oxygen SpeciesCancer-associated fibroblasts (CAF)Lung cancerMAPK signalingOxidative stressPhotodynamic therapy (PDT)

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.